LumiraDx Limited

LumiraDx Limited

Share · KYG5709L1178 · LMDXW (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of LumiraDx Limited
No Price
Company Profile for LumiraDx Limited Share
LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.

Company Data

Name LumiraDx Limited
Company LumiraDx Limited
Symbol LMDXW
Website http://www.lumiradx.com
Primary Exchange XNAS NASDAQ
ISIN KYG5709L1178
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Veronique Ameye EMBA,
Country United Kingdom
Currency USD
Employees 1,2 T
Address 3 More London Riverside, SE1 2AQ London
IPO Date 2021-09-29

Ticker Symbols

Name Symbol
NASDAQ LMDXW
More Shares
Investors who hold LumiraDx Limited also have the following shares in their portfolio:
RIVER AND MERCANTILE GROUP PLC - ORD GBP0.003
RIVER AND MERCANTILE GROUP PLC - ORD GBP0.003 Share
TOTALEN.CA.I 25/35 MTN
TOTALEN.CA.I 25/35 MTN Bond